share_log

HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target

Benzinga ·  Dec 17 06:18  · Ratings

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment